Madison Jones

Partner

I help public companies navigate the complex requirements of the capital markets.

madison.jones@cooley.com

Madison Jones practices corporate and securities law, representing late-stage private and publicly traded companies and underwriters, with a particular emphasis on capital markets transactions within two of the most rapidly growing industries: technology and life sciences. She has extensive experience counseling clients on the full range of general corporate and securities matters, including IPOs, public offerings, strategic corporate relationships, SEC reporting and compliance and corporate governance.

Download full bio 

Experience

  • MaxCyte – $202 Million IPO 

  • Werewolf Therapeutics – $120 Million IPO 

  • Olink Holding – $406 Million IPO 

  • Instil Bio – $368 Million IPO 

  • Landos Biopharma – $100 Million IPO 

  • View all

Passions

    Adventure Travel
    (I just climbed Mt. Kilimanjaro)

    Fashion

    Volunteer Work

Education

  • Duke University School of Law
    JD, 2011

  • Georgetown University
    BA, 2008


Admissions & Credentials

District of Columbia